Centroblastic (CB) and immunoblastic (IB) subtypes of diffuse large B cell lymphomas (DLBCL) have such a different clinical outcome that should be considered as separate entities in the WHO classification of lymphomas. A GISL study / Federico, Massimo; Artusi, T; Luminari, Stefano; Brugiatelli, M; Ricciotti, M; Marcheselli, L; Molica, S; Lombardo, M; Angrilli, F; Polimeno, G; Gobbi, P.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 16:(2005), pp. 97-97.
Centroblastic (CB) and immunoblastic (IB) subtypes of diffuse large B cell lymphomas (DLBCL) have such a different clinical outcome that should be considered as separate entities in the WHO classification of lymphomas. A GISL study
FEDERICO, Massimo;LUMINARI, Stefano;
2005
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
